Micro Text Module #3 with downloadable slides

TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer

Share

Program Content

Activities

  • Safety of ADCs in MBC: Module
    Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 07, 2024

    Expires: February 06, 2025

  • Safety of ADCs in MBC: Slides
    Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 07, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.